Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Vernerey

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2024
Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohortMatthieu Delaye, Alice Boilève, Julie Henriques, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
World Journal of Gastrointestinal Oncology|March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort studyAngélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
British Journal of Cancer|July 13, 2016
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.
European Heart Journal|September 2, 2014
MicroRNAs as non-invasive biomarkers of heart transplant rejectionJean-Paul Duong Van Huyen, Marion Tible, Arnaud Gay, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2015
Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patientsFrédéric Fiteni, Dewi Vernerey, Franck Bonnetain, et al.
BMC Cancer|October 27, 2016
Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric studyChristelle d'Engremont, Dewi Vernerey, Anne-Laure Pointet, et al.
Molecular Oncology|December 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort studyMarine Jary, Wen-Wei Liu, Dongyao Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trialAlice Boilève, Marc Hilmi, Paul Gougis, et al.
BMC Cancer|May 17, 2023
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN studyChloé Drozd, Elsa Curtit, Quentin Jacquinot, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2024
Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohortMatthieu Delaye, Alice Boilève, Julie Henriques, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
World Journal of Gastrointestinal Oncology|March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort studyAngélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
British Journal of Cancer|July 13, 2016
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.
European Heart Journal|September 2, 2014
MicroRNAs as non-invasive biomarkers of heart transplant rejectionJean-Paul Duong Van Huyen, Marion Tible, Arnaud Gay, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2015
Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patientsFrédéric Fiteni, Dewi Vernerey, Franck Bonnetain, et al.
BMC Cancer|October 27, 2016
Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric studyChristelle d'Engremont, Dewi Vernerey, Anne-Laure Pointet, et al.
Molecular Oncology|December 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort studyMarine Jary, Wen-Wei Liu, Dongyao Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trialAlice Boilève, Marc Hilmi, Paul Gougis, et al.
BMC Cancer|May 17, 2023
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN studyChloé Drozd, Elsa Curtit, Quentin Jacquinot, et al.
Pageof 16